Pisella PJ, et al. - This study was performed to evaluate the efficacy and safety of cyclosporine A cationic emulsion (CsA CE) 0.1% for the treatment of severe keratitis in adults with dry eye disease (DED) in a French early-access program. Findings supported that CsA CE was clinically beneficial for improving/stabilizing symptoms and corneal damage in DED patients with severe keratitis in real-world clinical practice.